Role of RelA and SpoT in burkholderia pseudomallei virulence and immunity

Infection and Immunity

Volumn 80, Issue 9, 2012, Pages 3247-3255

  Müller, Claudia M ^a,c   Conejero, Laura ^b   Spink, Natasha ^b   Wand, Matthew E ^a   Bancroft, Gregory J ^b   Titball, Richard W ^a  

^a UNIVERSITY OF EXETER   (United Kingdom)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^c PUBLIC HEALTH ENGLAND   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL ENZYME; BURKHOLDERIA PSEUDOMALLEI RELA SPOT DOUBLE MUTANT; LIVE VACCINE; MUTANT PROTEIN; SPOT PROTEIN; TRANSCRIPTION FACTOR RELA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL IMMUNITY; BACTERIAL REPRODUCTION; BACTERIAL STRAIN; BACTERIAL SURVIVAL; BACTERIAL VIRULENCE; BACTERIUM MUTANT; BURKHOLDERIA PSEUDOMALLEI; CONTROLLED STUDY; FEMALE; GALLERIA MELLONELLA; GENE EXPRESSION; IN VITRO STUDY; IN VIVO STUDY; MACROPHAGE; MELIOIDOSIS; MICROBIAL ATTENUATION; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; VACCINATION; WILD TYPE;

ANIMALS; BACTERIAL VACCINES; BURKHOLDERIA PSEUDOMALLEI; DISEASE MODELS, ANIMAL; FEMALE; GENE DELETION; HUMANS; LEPIDOPTERA; LIGASES; MACROPHAGES; MELIOIDOSIS; MICE; MICE, INBRED C57BL; MICROBIAL VIABILITY; PYROPHOSPHATASES; SURVIVAL ANALYSIS; VACCINES, ATTENUATED; VIRULENCE; VIRULENCE FACTORS;

EID: 84867587883     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.00178-12     Document Type: Article

References (50)

1. Åberg A, Shingler V, Balsalobre C. 2008. Regulation of the fimB promoter: a case of differential regulation by ppGpp and DksA in vivo. Mol. Microbiol. 67:1223-1241.
2. Atkins T, et al. 2002. Characterisation of an acapsular mutant of Burkholderia pseudomallei identified by signature tagged mutagenesis. J. Med. Microbiol. 51:539-553.
3. Atkins T, et al. 2002. A mutant of Burkholderia pseudomallei, auxotrophic in the branched chain amino acid biosynthetic pathway, is attenuated and protective in a murine model of melioidosis. Infect. Immun. 70:5290-5294.
4. Atkinson GC, Tenson T, Hauryliuk V. 2011. The RelA/SpoT homolog (RSH) superfamily: distribution and functional evolution of ppGpp synthetases and hydrolases across the tree of life. PLoS One 6:e23479. doi: 10.1371/journal.pone.0023479.
5. Braeken K, Moris M, Daniels R, Vanderleyden J, Michiels J. 2006. New horizons for (p)ppGpp in bacterial and plant physiology. Trends Microbiol. 14:45-54.
6. Cashel M, Gentry D, Hernandez VJ, Vinella D. 1996. The stringent response, p 1458-1496. In Neidhardt FC, Curtiss R III, Ingraham JL, Lin ECC, Low KB, Magasanik B, Reznikoff WS, Riley M, Schaechter M, Umbarger HE (ed), Escherichia coli and Salmonella: cellular and molecular biology. ASM Press, Washington, DC.
7. Cheng AC, Currie BJ. 2005. Melioidosis: epidemiology, pathophysiology, and management. Clin. Microbiol. Rev. 18:383-416.
8. Conejero L, et al. 2011. Low-dose exposure of C57BL/6 mice to Burkholderia pseudomallei mimics chronic human melioidosis. Am. J. Pathol. 179:270-280.
9. Currie BJ, Fisher DA, Anstey NM, Jacups SP. 2000. Melioidosis: acute and chronic disease, relapse and re-activation. Trans. R. Soc. Trop. Med. Hyg. 94:301-304.
10. Dahl JL, et al. 2003. The role of RelMtb-mediated adaptation to stationary phase in long-term persistence of Mycobacterium tuberculosis in mice. Proc. Natl. Acad. Sci. U. S. A. 100:10026-10031.
11. Dalebroux ZD, Edwards RL, Swanson MS. 2009. SpoT governs Legionella pneumophila differentiation in host macrophages. Mol. Microbiol. 71:640-658.
12. Dalebroux ZD, Svensson SL, Gaynor EC, Swanson MS. 2010. ppGpp conjures bacterial virulence. Microbiol. Mol. Biol. Rev. 74:171-199.
13. Dannenberg AM, Jr, Scott EM. 1958. Melioidosis: pathogenesis and immunity in mice and hamsters. I. Studies with virulent strains of Malleomyces pseudomallei. J. Exp. Med. 107:153-166.
14. Dannenberg AM, Jr, Scott EM. 1958. Melioidosis: pathogenesis and immunity in mice and hamsters. II. Studies with avirulent strains of Malleomyces pseudomallei. Am. J. Pathol. 34:1099-1121.
15. Dannenberg AM, Jr, Scott EM. 1960. Melioidosis: pathogenesis and immunity in mice and hamsters. III. Effect of vaccination with avirulent strains of Pseudomonas pseudomallei on the resistance to the establishment and the resistance to the progress of respiratory melioidosis caused by virulent strains; all-or-none aspects of this disease. J. Immunol. 84:233-246.
16. Dean RE, Ireland PM, Jordan JE, Titball RW, Oyston PCF. 2009. RelA regulates virulence and intracellular survival of Francisella novicida. Microbiology 155:4104-4113.
17. Dozot M, et al. 2006. The stringent response mediator Rsh is required for Brucella melitensis and Brucella suis virulence, and for expression of the type IV secretion system virB. Cell. Microbiol. 8:1791-1802.
18. Durfee T, Hansen A-M, Zhi H, Blattner FR, Jin DJ. 2008. Transcriptionprofiling of the stringent response in Escherichia coli. J. Bacteriol. 190: 1084-1096.
19. Easton A, et al. 2011. Combining vaccination and postexposure CpG therapy provides optimal protection against lethal sepsis in a biodefense model of human melioidosis. J. Infect. Dis. 204:636-644.
20. Fisher SD, Reger AD, Baum A, Hill SA. 2005. RelA alone appears essential for (p)ppGpp production when Neisseria gonorrhoeae encounters nutritional stress. FEMS Microbiol. Lett. 248:1-8.
21. Gaynor EC, Wells DH, MacKichan JK, Falkow S. 2005. The Campylobacter jejuni stringent response controls specific stress survival and virulence-associated phenotypes. Mol. Microbiol. 56:8-27.
22. Haque A, et al. 2006. Role of T cells in innate and adaptive immunity against murine Burkholderia pseudomallei infection. J. Infect. Dis. 193: 370-379.
23. Holden MTG, et al. 2004. Genomic plasticity of the causative agent of melioidosis, Burkholderia pseudomallei. Proc. Natl. Acad. Sci. U. S. A. 101: 14240-14245.
24. Kim S, Watanabe K, Suzuki H, Watarai M. 2005. Roles of Brucella abortus SpoT in morphological differentiation and intramacrophagic replication. Microbiology 151:1607-1617.
25. Koulich D, et al. 1997. Domain organization of Escherichia coli transcript cleavage factors GreA and GreB. J. Biol. Chem. 272:7201-7210.
26. Logue C-A, Peak IRA, Beacham IR. 2009. Facile construction of unmarked deletion mutants in Burkholderia pseudomallei using sacB counter-selection in sucrose-resistant and sucrose-sensitive isolates. J. Microbiol. Methods 76:320-323.
27. Magnusson LU, Farewell A, Nyström T. 2005. ppGpp: a global regulator in Escherichia coli. Trends Microbiol. 13:236-242.
28. Marchler-Bauer A, et al. 2011. CDD: a conserved domain database for the functional annotation of proteins. Nucleic Acids Res. 39:D225-D229.
29. Milton DL, O'Toole R, Horstedt P, Wolf-Watz H. 1996. Flagellin A is essential for the virulence of Vibrio anguillarum. J. Bacteriol. 178:1310-1319.
30. Mittenhuber G. 2001. Comparative genomics and evolution of genes encoding bacterial (p)ppGpp synthetases/hydrolases (the Rel, RelA and SpoT proteins). J. Mol. Microbiol. Biotechnol. 3:585-600.
31. Mouery K, Rader BA, Gaynor EC, Guillemin K. 2006. The stringent response is required for Helicobacter pylori survival of stationary phase, exposure to acid, and aerobic shock. J. Bacteriol. 188:5494-5500.
32. Murphy H, Cashel M. 2003. Isolation of RNA polymerase suppressors of a (p)ppGpp deficiency. Methods Enzymol. 371:596-601.
33. Na HS, et al. 2006. Immune response induced by Salmonella typhimurium defective in ppGpp synthesis. Vaccine 24:2027-2034.
34. Nascimento MM, Lemos JA, Abranches J, Lin VK, Burne RA. 2008. Role of RelA of Streptococcus mutans in global control of gene expression. J. Bacteriol. 190:28-36.
35. Norris MH, et al. 2011. The Burkholderia pseudomallei asd mutant exhibits attenuated intracellular infectivity and imparts protection against acute inhalation melioidosis in mice. Infect. Immun. 79:4010-4018.
36. Nyström T. 2004. Stationary-phase physiology. Annu. Rev. Microbiol. 58:161-181.
37. Park S-I, et al. 2010. Immune response induced by ppGpp-defective Salmonella enterica serovar Gallinarum in chickens. J. Microbiol. 48:674-681.
38. Patel N, et al. 2011. Development of vaccines against Burkholderia pseudomallei. Front. Microbiol. 2:198. doi:10.3389/fmicb.2011.00198.
39. Potrykus K, Cashel M. 2008. (p) ppGpp: still magical? Annu. Rev. Microbiol. 62:35-51.
40. Potrykus K, et al. 2006. Antagonistic regulation of Escherichia coli ribosomal RNA rrnB P1 promoter activity by GreA and DksA. J. Biol. Chem. 281:15238-15248.
41. Primm TP, et al. 2000. The stringent response of Mycobacterium tuberculosis is required for long-term survival. J. Bacteriol. 182:4889-4898.
42. Sarkar-Tyson M, Titball RW. 2010. Progress toward development of vaccines against melioidosis: a review. Clin. Ther. 32:1437-1445.
43. Simon R, Priefer U, Puhler A. 1983. A broad host range mobilization system for in vivo genetic engineering: transposon mutagenesis in gram negative bacteria. Nat. Biotechnol. 1:784-791.
44. Sun W, Roland KL, Branger CG, Kuang X, Curtiss RIII. 2009. The role of relA and spoT in Yersinia pestis KIM5_ pathogenicity. PLoS One 4:e6720. doi:10.1371/journal.pone.0006720.
45. Titball RW, et al. 2008. Burkholderia pseudomallei: animal models of infection. Trans. R. Soc. Trop. Med. Hyg. 102:S111-S116.
46. Traxler MF, Chang D-E, Conway T. 2006. Guanosine 3=,5=-bispyrophosphate coordinates global gene expression during glucose-lactose diauxie in Escherichia coli. Proc. Natl. Acad. Sci. U. S. A. 103:2374-2379.
47. Wand M, Müller C, Titball R, Michell S. 2010. Macrophage and Galleria mellonella infection models reflect the virulence of naturally occurring isolates of B. pseudomallei, B. thailandensis and B. oklahomensis. BMC Microbiol. 11:11.
48. Wiersinga WJ, van der Poll T, White NJ, Day NP, Peacock SJ. 2006. Melioidosis: insights into the pathogenicity of Burkholderia pseudomallei. Nat. Rev. Microbiol. 4:272-282.
49. Zhou YN, et al. 2008. Regulation of cell growth during serum starvation and bacterial survival in macrophages by the bifunctional enzyme SpoT in Helicobacter pylori. J. Bacteriol. 190:8025-8032.
50. Zhou YN, Jin DJ. 1998. The rpoB mutants destabilizing initiation complexes at stringently controlled promoters behave like "stringent" RNA polymerases in Escherichia coli. Proc. Natl. Acad. Sci. U. S. A. 95:2908-2913.